首页 | 本学科首页   官方微博 | 高级检索  
     

微小RNA-126和微小RNA-7在食管鳞状细胞癌中的表达及临床意义
引用本文:王江峰,凌志强,毛伟敏. 微小RNA-126和微小RNA-7在食管鳞状细胞癌中的表达及临床意义[J]. 国外医学(肿瘤学分册), 2013, 0(12): 936-940
作者姓名:王江峰  凌志强  毛伟敏
作者单位:浙江省肿瘤研究所,杭州310022
基金项目:卫生部科研基金(WKJ2010-2-004);浙江省重大科技专项计划项目(2011C13039-1)
摘    要:目的探讨微小RNA-126(miR-126)和微小RNA-7(miR-7)在食管鳞状细胞癌(ESCC)中的表达情况及其与ESCC临床病理特征、预后之间的关系。方法采用实时荧光定量聚合酶链反应法检测116例ESCC组织和癌旁正常组织中miR-126和miR-7的表达差异,并对miR-126和miR-7表达情况与ESCC患者临床病理特征、预后的相关性进行统计学分析。结果miR-126不同程度低表达病例数为73(62.9%),正常表达病例数为35(30.2%),高表达病例数为8(6.9%);miR-7不同程度低表达病例数为52(44.8%),正常表达病例数为35(30.2%),高表达病例数为29(25.0%)。miR-126和miR-7表达降低组无瘤生存期均较非降低组短(r=4.268,P〈0.05;x2=4.993,P〈0.05);miR-126低表达与ESCC肿瘤位置、家族史和饮酒相关(Xz=14.564,P〈0.05,x2=5.691,P〈0.05;X2=4.971,P〈0.05),与性别、年龄、分化程度、浸润程度、淋巴转移、吸烟不相关(均P〉0.05);miR-7低表达与ESCC的临床病理特征均不相关(均P〉O.05)。结论miR-126和miR-7的低表达可能与ESCC患者预后相关,具有一定的临床检测意义。

关 键 词:食管肿瘤  预后  微小RNA-126  微小RNA-7

Expressions and clinical signfficances of microRNA-126 and microRNA-7 in esophageal squamons cell carcinoma
WANG Jiang-feng,LING Zhi-qiang,MAO Wei-min. Expressions and clinical signfficances of microRNA-126 and microRNA-7 in esophageal squamons cell carcinoma[J]. Foreign Medical Sciences (Cancer Section), 2013, 0(12): 936-940
Authors:WANG Jiang-feng  LING Zhi-qiang  MAO Wei-min
Affiliation:. Zhejiang Cancer Research Institute, Hang- zhou 310022, China
Abstract:Objective To detect the expressions of microRNA-126 (miR-126) and microRNA-7 (miR-7) in esophageal squamous cell carcinoma (ESCC) and to analyze their correlations with clinicopatho- logic features and prognosis of ESCC. Methods The expressions of miR-126 and miR-7 in 116 ESCC samples and matched normal tissue samples were detected by real-time PCR. Statistical analysis was used to find the relationships among the expressions of miR-126 and miR-7, pathological characteristics and prognosis. Results Low expression, normal expression and high expression of miR-126 were found in 73 (62.9%), 35 (30.2%) and 8 (6.9%) carcinoma samples respectively. Low expression, normal expression and high expression of miR-7 were found in 52 (44.8%), 35 (30.2%) and 29 (25.0%) carcinoma samples respectively. The dis- ease-free survival in patients with low expression of miR-126 and miR-7 was shorter than that in patients with non-low expression (X2 = 4.268, P 〈 0.05 ; X2 = 4. 993, P 〈 0.05 ). The low expression of miR-126 was corre- lated with tumor location, family history and drinking (X2 = 14. 564, P 〈 0.05 ; X2 = 5. 691, P 〈 0.05 ; X2 = 4. 971, P 〈 0.05), but was uncorrelated with gender, age, differentiation, infiltration, lymphatic metastasis and smoking ( all P 〉 0.05). The low expression of miR-7 was uncorrelated with pathological characteristics of ESCC ( all P 〉 0.05 ). Conclusion The low expressions of miR-126 and miR-7 may be related to the progno- sis of patients with ESCC, and have a certain clinical detection significance.
Keywords:Esophageal neoplasms  Prognosis  MicroRNA-126  MicroRNA-7
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号